Caeregen Therapeutics is committed to finding and creating innovative medicinal solutions.
Caeregen Therapeutics has raised $1.4M in total funding. The most recent round was Grant. The last funding was announced in July 2023.
Caeregen Therapeutics's investors include National Institutes of Health, National Eye Institute.
Caeregen Therapeutics is headquartered in Chapel Hill, United States.
Caeregen Therapeutics is committed to finding and creating innovative medicinal solutions.
Caeregen Therapeutics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Caeregen Therapeutics — Funding & Investors." VCBacked, July 17, 2023, https://www.vcbacked.co/company/caeregen-therapeutics. Accessed July 19, 2026.
VCBacked. (2023). Caeregen Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/caeregen-therapeutics
{{cite web |title=Caeregen Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/caeregen-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated